Vaccination with HPV16mE7 pulsed, shRNA-mediated SOCS1-silenced DCs showed significantly improved anti-tumor effects compared to non-SOCS1-silenced controls in vitro and in vivo (103). This evidence concerns the gene SOCS1 and neoplasm.